Moreover, EVs can affect receptor cell function, and dormant cancer cell-derived EVs promote PMN formation and cancer cell survival in the bone marrow by reprogramming the metabolic processes of bone marrow mesenchymal cells through the transfer of EVs IGF-2 and IGFBP2 [198]. Here, IGFBP2 is linked to cancer.